Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact

@article{Hungin2005IrritableBS,
  title={Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact},
  author={A P S Hungin and L. Chang and Giles Richard Locke and Eslie Dennis and Victoria E Barghout},
  journal={Alimentary Pharmacology \& Therapeutics},
  year={2005},
  volume={21}
}
Background : The impact of irritable bowel syndrome, a gastrointestinal motility disorder, is underestimated and poorly quantified, as clinicians may see only a minority of sufferers. 

Paper Mentions

Prevalence and demographics of irritable bowel syndrome: results from a large web‐based survey
TLDR
This work has shown clear trends in the prevalence and demographics of irritable bowel syndrome among women over the age of 40, and these trends have continued to improve since the 1970s. Expand
Review article: the economic impact of the irritable bowel syndrome
TLDR
A large number of people worldwide have IBS, and it has substantial impact on patients' quality of life (QoL) and is associated with considerable healthcare resource use. Expand
Systematic review: the perceptions, diagnosis and management of irritable bowel syndrome in primary care – A Rome Foundation Working Team Report
TLDR
To review studies on the perceptions, diagnosis and management of irritable bowel syndrome (IBS) in primary care, a large number of studies from around the world have been reviewed. Expand
Meeting the challenge of IBS.
TLDR
This study highlights the need to understand more fully the mechanism behind the development and management of irritable bowel syndrome, which is often characterized by crippling symptoms without any pathologic findings. Expand
The epidemiology of irritable bowel syndrome: Symptom development over a 3‐year period in Denmark. A prospective, population‐based cohort study
TLDR
The natural history of irritable bowel syndrome in Denmark over 3 years was explored by studying development of IBS symptoms and associated factors. Expand
Use of Treatments for Irritable Bowel Syndrome and Patient Satisfaction, Based on IBS in America Survey.
TLDR
Many treatments for irritable bowel syndrome are available to those with the disease, but satisfaction is low, and a need exists for further effective treatments for the condition. Expand
Meta‐analysis: do irritable bowel syndrome symptoms vary between men and women?
TLDR
This data indicates that sex and gender‐related differences exist in irritable bowel syndrome (IBS), but data is often conflicting and research is needed to confirm these differences. Expand
Physical and psychological co‐morbidity in irritable bowel syndrome: a matched cohort study using the General Practice Research Database
TLDR
Little information is available concerning physical and psychological comorbidity in irritable bowel syndrome patients studied over an extended period, but attempts are made to clarify the relationship between these conditions and each other. Expand
Significant psychological morbidity occurs in irritable bowel syndrome: a case‐control study using a pharmacy reimbursement database
TLDR
A large number of patients with psychological problems are diagnosed with IBS, but the strength of this association is unclear and the causes are still poorly understood. Expand
In‐patient discharge rates for the irritable bowel syndrome – an analysis of national trends in the United States from 1997 to 2010
TLDR
There are limited data on the rate and costs associated with in‐patient discharges for IBS, and the most common out‐patient diagnoses in primary care and gastroenterology is IBS. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 42 REFERENCES
The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects
TLDR
To determine the prevalence, symptom pattern and impact of the irritable bowel syndrome, across eight European countries, using a standardized methodology, the aim was to establish a standard methodology and establish a baseline for this study. Expand
AGA technical review on irritable bowel syndrome.
TLDR
Psychosocial factors, although not part of IBS per se, have an important role in modulating the illness experience and its clinical outcome. Expand
Management of irritable bowel syndrome.
TLDR
Episodes of diarrhea are best managed with loperamide, while constipation often will respond to fiber supplements, and antispasmodics or anticholinergic agents may help relieve the abdominal pain of irritable bowel syndrome. Expand
Women With Irritable Bowel Syndrome: Differences in Patients’ and Physicians’ Perceptions
TLDR
A national survey was undertaken to describe the attitudes, knowledge, treatment strategies, and compliance of women with IBS, and determine whether physician gender influenced patient satisfaction. Expand
The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology, and Treatment : A Multinational Consensus
TLDR
This book presents a single source of standardized definitions, diagnostic criteria and treatment recommendations forFunctional gastrointestinal disorders, which should no longer need to make a diagnosis of exclusion. Expand
Clinical Assessment of Irritable Bowel Syndrome
Because irritable bowel syndrome (IBS) is a prevalent cause of visits to the gastroenterologist, it is extremely important to have accurate guidelines for the diagnosis. During the clinicalExpand
Irritable bowel syndrome: definition, diagnosis and epidemiology.
  • N. Talley
  • Medicine
  • Bailliere's best practice & research. Clinical gastroenterology
  • 1999
TLDR
The development of acceptable, symptom-based diagnostic criteria has advanced the field, stimulating interest in the pathophysiology and targeted pharmacological therapy, which are essential steps if the disease burden is to be reduced. Expand
Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?
TLDR
Multivariate statistical analyses suggest that gastrointestinal disorders, psychiatric disorders, and nongastrointestinal somatic disorders are distinct disorders and not manifestations of a common somatization disorder, but their strong comorbidity suggests a common feature important to their expression, which is most likely psychological. Expand
Review article: irritable bowel syndrome
TLDR
Irritable bowel syndrome is the most common disease diagnosed by gastroenterologists and affects about 20% of all people at any one time; the illness has a large economic impact on health‐care utilization and absenteeism. Expand
Economic burden of irritable bowel syndrome. Proposed strategies to control expenditures.
It has been suggested that the annual direct costs for irritable bowel syndrome (IBS) are now around $US41 billion in the 8 most industrialised countries. This paper reviews the data on calculationsExpand
...
1
2
3
4
5
...